12 participants from #EAC Partner States, supported by @eacrcevihsm, are set to gain valuable learning experience from the ongoing 2-week ’ 2024 Introductory Course for Biologics Development and Manufacturing’ training, hosted by
@IVIHeadquarters in Seoul, South Korea!
As part of our ongoing upskilling endeavors, this aligns with the commitment of the Partnerships for African Vaccine Manufacturing (PAVM) Framework for Action which seeks to empower Africa’s vaccine and pharmaceutical industries to become self-sufficient.
